Výsledky vyhledávání - Michael J. Hanley

  • Zobrazuji výsledky 1 - 10 z 10
Upřesnit hledání
  1. 1
    The effect of grapefruit juice on drug disposition

    The effect of grapefruit juice on drug disposition Autor Michael J. Hanley, Paul Cancalon, Wilbur Widmer, David J. Greenblatt

    Vydáno 2011
    Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Mobocertinib: Mechanism of action, clinical, and translational science

    Mobocertinib: Mechanism of action, clinical, and translational science Autor Michael J. Hanley, D. Ross Camidge, Robert J. Fram, Neeraj Gupta

    Vydáno 2024
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Clinical Pharmacology of Ixazomib: The First Oral Proteasome Inhibitor

    Clinical Pharmacology of Ixazomib: The First Oral Proteasome Inhibitor Autor Neeraj Gupta, Michael J. Hanley, Cindy Q. Xia, Richard Labotka, R. Donald Harvey, Karthik Venkatakrishnan

    Vydáno 2018
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Population Pharmacokinetic Analysis of Ixazomib, an Oral Proteasome Inhibitor, Including Data from the Phase III TOURMALINE-MM1 Study to Inform Labelling

    Population Pharmacokinetic Analysis of Ixazomib, an Oral Proteasome Inhibitor, Including Data from the Phase III TOURMALINE-MM1 Study to Inform Labelling Autor Neeraj Gupta, Paul M. Diderichsen, Michael J. Hanley, Deborah Berg, Helgi van de Velde, R. Donald Harvey, Karthik Venkatakrishnan

    Vydáno 2017
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Effect of a herbal extract containing curcumin and piperine on midazolam, flurbiprofen and paracetamol (acetaminophen) pharmacokinetics in healthy volunteers

    Effect of a herbal extract containing curcumin and piperine on midazolam, flurbiprofen and paracetamol (acetaminophen) pharmacokinetics in healthy volunteers Autor Laurie P. Volak, Michael J. Hanley, G Massé, Suwagmani Hazarika, Jerold S. Harmatz, Vladimir Badmaev, Muhammed Majeed, David J. Greenblatt, Michael H. Court

    Vydáno 2012
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Coronary Microvascular Dysfunction Is Related to Abnormalities in Myocardial Structure and Function in Cardiac Amyloidosis

    Coronary Microvascular Dysfunction Is Related to Abnormalities in Myocardial Structure and Function in Cardiac Amyloidosis Autor Sharmila Dorbala, Divya Vangala, John Bruyere, Candida Cristina Quarta, Jenna Kruger, Robert F. Padera, Courtney Foster, Michael J. Hanley, Marcelo F. Di Carli, Rodney H. Falk

    Vydáno 2014
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    Pharmacokinetics of ixazomib, an oral proteasome inhibitor, in solid tumour patients with moderate or severe hepatic impairment

    Pharmacokinetics of ixazomib, an oral proteasome inhibitor, in solid tumour patients with moderate or severe hepatic impairment Autor Neeraj Gupta, Michael J. Hanley, Karthik Venkatakrishnan, Raymond P. Perez, Robin E. Norris, John Nemunaitis, Huyuan Yang, Mark G. Qian, Gerald S. Falchook, Richard Labotka, Siqing Fu

    Vydáno 2016
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    A pharmacokinetics and safety phase 1/1b study of oral ixazomib in patients with multiple myeloma and severe renal impairment or end‐stage renal disease requiring haemodialysis

    A pharmacokinetics and safety phase 1/1b study of oral ixazomib in patients with multiple myeloma and severe renal impairment or end‐stage renal disease requiring haemodialysis Autor Neeraj Gupta, Michael J. Hanley, R. Donald Harvey, Ashraf Badros, Brea Lipe, Vishal Kukreti, Jesús G. Berdeja, Huyuan Yang, Ai‐Min Hui, Mark G. Qian, Xiaoquan Zhang, Karthik Venkatakrishnan, Ajai Chari

    Vydáno 2016
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Randomized, double-blind, placebo-controlled phase III study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma: China Continuation study

    Randomized, double-blind, placebo-controlled phase III study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma: China Continuation s... Autor Jian Hou, Jie Jin, Yan Xu, Depei Wu, Xiaoyan Ke, Daobin Zhou, Jin Lu, Xin Du, Xiequn Chen, Junmin Li, Jing Liu, Neeraj Gupta, Michael J. Hanley, Hongmei Li, Zhaowei Hua, Bingxia Wang, Xiaoquan Zhang, Hui Wang, Helgi van de Velde, Paul G. Richardson, Philippe Moreau

    Vydáno 2017
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    Brigatinib Versus Crizotinib in Advanced ALK Inhibitor–Naive ALK-Positive Non–Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial

    Brigatinib Versus Crizotinib in Advanced ALK Inhibitor–Naive ALK-Positive Non–Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial Autor D. Ross Camidge, Hye Ryun Kim, Myung‐Ju Ahn, James Chih‐Hsin Yang, Ji‐Youn Han, Maximilian J. Hochmair, Ki Hyeong Lee, Angelo Delmonte, M.R. García Campelo, Dong‐Wan Kim, Frank Griesinger, Enriqueta Felip, Raffaele Califano, Alexander I. Spira, Scott Gettinger, Marcello Tiseo, Huamao Mark Lin, Neeraj Gupta, Michael J. Hanley, Quanhong Ni, Pingkuan Zhang, Sanjay Popat

    Vydáno 2020
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: